Statins: Benefits and Myths — Who Needs Them and What Not to Fear
What statins actually do to your risk of heart attack and stroke, where the myths about muscle pain, diabetes and memory come from, and who really needs them.
Contents
Statins lower LDL cholesterol and, with it, the risk of heart attack and stroke: each millimole of LDL reduction removes about a fifth of the risk of major events per year. Meanwhile most of the scary stories about statins do not hold up in blinded trials — muscle pain more often turns out to be the expectation of a side effect than its cause. Here is what is proven, what is exaggerated, and who really needs them.
What statins actually do
Statins block HMG-CoA reductase — the key step in the liver's cholesterol synthesis. In response, the liver pulls more LDL out of the blood, and its level falls. This is not cosmetic: LDL is a causal driver of atherosclerosis, and lowering it directly slows plaque growth.
The scale of the benefit is measured more precisely than for almost any other drug. In the Cholesterol Treatment Trialists meta-analysis of more than 170,000 participants, each 1 mmol/L drop in LDL cut the risk of major cardiovascular events by about 21% per year. The effect compounds: the longer LDL stays low, the wider the gap from those who go untreated.
Who really needs them
The key to benefit is baseline risk. The same percentage reduction gives very different absolute gains in someone after a heart attack versus a healthy forty-year-old.
| Situation | Statins indicated? | Why |
|---|---|---|
| Already had a heart attack or stroke | Yes, almost always | Highest absolute risk — highest benefit |
| Diabetes, age 40–75 | Usually yes | Diabetes itself raises risk |
| High calculated risk (SCORE2) | Yes, discussed with a doctor | Prevention before the first event |
| Very high LDL (familial form) | Yes | Lifelong high cholesterol burden |
| Low risk, moderate LDL | Usually no | Small absolute benefit; start with lifestyle |
You can gauge your own risk in advance — from the same labs a doctor uses.
Читайте также: Heart Attack & Stroke Risk Calculator (SCORE2)
Myth one: "statins cause muscle pain"
This is the most common reason people stop — and the most thoroughly debunked myth. Real statin-caused muscle pain occurs in under 1% above placebo in blinded trials. Dangerous muscle breakdown (rhabdomyolysis) is very rare.
So why so many complaints? The SAMSON trial answered it: participants took a statin, a placebo and nothing in turn, blinded to which. Symptoms appeared equally on statin and placebo — and barely appeared with no tablet at all. This is the nocebo effect: expecting a side effect creates it. The practical takeaway is not to quit at the first ache, but to discuss a pause, a different statin, or a lower dose with a doctor.
Myth two: "statins cause diabetes"
Here there is a grain of truth. A meta-analysis found about 1 new case of diabetes per 255 people over 4 years of treatment — mostly in those already on the edge for weight and blood sugar. But the scale is not comparable: over the same period statins prevent several times as many heart attacks and strokes. Trading away heart protection over a small glucose shift is a bad deal.
Myths three and four: memory and liver
Fears about "brain fog" and dementia have not held up: systematic reviews find no link between statins and memory loss or cognitive decline. Meaningful liver injury is also very rare — so rare that routine monitoring of liver enzymes on statins is no longer required. A mild rise in ALT can occur and usually does not require stopping.
What to make of all this
Statins are neither a life sentence nor a "preventive vitamin for everyone". They are a precise tool matched to a specific risk. If risk is high or an event has already happened, the benefit far outweighs the minor inconveniences. If risk is low, it is reasonable to start with what lowers LDL without tablets and revisit the question by the numbers.
Читайте также: Cholesterol: LDL, HDL and what actually lowers risk
Читайте также: Lipoprotein(a): the test worth doing once in your life
No statin decision is made from an article online: it is built on your risk, your labs and your other conditions — and that is a conversation with a doctor. The job of this piece is to make sure you walk into that conversation without needless fear.
FAQ
How much do statins cut the risk of a heart attack?+
Each 1 mmol/L drop in LDL lowers the risk of major cardiovascular events by about 21% per year, per the CTT meta-analysis of more than 170,000 people. The absolute benefit is largest where baseline risk is highest — greatest in people who have already had a heart attack.
Is it true that statins cause muscle pain?+
Real statin-caused muscle pain is rare — under 1 in 100 above placebo in blinded trials. In the SAMSON trial, pain appeared equally on statin and placebo: it is largely a nocebo effect, driven by expecting a side effect. Dangerous muscle breakdown (rhabdomyolysis) is very rare.
Do statins cause diabetes?+
There is a small risk: roughly 1 new case of diabetes per 255 people over 4 years, mostly in those already near the threshold. It is far outweighed by the heart attacks and strokes prevented, and is not a reason to decline them when indicated.
Do statins harm memory or the liver?+
No link between statins and memory loss or dementia has been confirmed in studies. Meaningful liver injury is very rare, and routine enzyme monitoring is no longer required. A mild rise in ALT can occur and usually does not require stopping.
Can I skip statins by lowering cholesterol through lifestyle?+
Diet, weight, quitting smoking and activity lower LDL by 10–15% — enough at low risk. But at high risk, with very high LDL, or after an event, lifestyle is not enough, and statins deliver what diet cannot.
References
- 1.Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol. Lancet, 2010
- 2.Wood FA et al. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects (SAMSON). N Engl J Med, 2020
- 3.Sattar N et al. Statins and risk of incident diabetes: a collaborative meta-analysis. Lancet, 2010
- 4.US Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults. JAMA, 2022
- 5.Mach F et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 2020
Read next
Coronary Calcium Score (CAC): What a Heart CT Calcium Scan Shows
What the coronary calcium score is, what the Agatston numbers mean, who it genuinely helps decide about statins, and who does not need it.

Cholesterol Explained: LDL, HDL and Triglycerides
Read your lipid panel without panic: what LDL, HDL and triglycerides mean, which LDL targets apply to your risk, and how to lower it with food and statins.

Lipoprotein(a): The Test Worth Doing Once in Your Life
What Lp(a) is, why it is 90% genetic, who should measure it and when, what to do about a high result, and why statins barely touch it.